Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy

In oncotherapy, ruthenium (Ru) complexes are reflected as potential alternatives for platinum compounds and have been proved as encouraging anticancer drugs with high efficacy and low side effects. Cardiovascular diseases (CVDs) are mutually considered as the number one killer globally, and thrombos...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayakumar, Thanasekaran, Hsu, Chia-Yuan, Khamrang, Themmila, Hsia, Chih-Hsuan, Hsia, Chih-Wei, Manubolu, Manjunath, Sheu, Joen-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032250/
https://www.ncbi.nlm.nih.gov/pubmed/29925802
http://dx.doi.org/10.3390/ijms19061818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032250/
https://www.ncbi.nlm.nih.gov/pubmed/29925802
http://dx.doi.org/10.3390/ijms19061818

Ejemplares similares